148 related articles for article (PubMed ID: 34761611)
21. Prevalence of neuropathic pain in radiotherapy oncology units.
Mañas A; Monroy JL; Ramos AA; Cano C; López-Gómez V; Masramón X; Pérez M;
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):511-20. PubMed ID: 20832183
[TBL] [Abstract][Full Text] [Related]
22. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
23. Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation.
Onseng K; Johns NP; Khuayjarernpanishk T; Subongkot S; Priprem A; Hurst C; Johns J
J Altern Complement Med; 2017 Dec; 23(12):957-963. PubMed ID: 28657801
[TBL] [Abstract][Full Text] [Related]
24. Agreement Between the Douleur Neuropathique in 4 Questions and Leeds Assessment of Neuropathic Symptoms and Signs Questionnaires to Classify Neuropathic Pain Among Patients with Leprosy.
Santana JC; Santos VS; Gurgel RQ; Santana JC; Reis FP; Cuevas LE; Feitosa VL
Am J Trop Med Hyg; 2016 Oct; 95(4):756-759. PubMed ID: 27458041
[TBL] [Abstract][Full Text] [Related]
25. Randomized trial of opioids versus tricyclic antidepressants for radiation-induced mucositis pain in head and neck cancer.
Ehrnrooth E; Grau C; Zachariae R; Andersen J
Acta Oncol; 2001; 40(6):745-50. PubMed ID: 11765070
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of Adjunctive Analgesics in Head and Neck Cancer Patients Receiving Curative (Chemo-) Radiotherapy: A Systematic Review.
Lefebvre T; Tack L; Lycke M; Duprez F; Goethals L; Rottey S; Cool L; Van Eygen K; Stubbs B; Schofield P; Pottel H; Boterberg T; Debruyne P
Pain Med; 2021 Feb; 22(1):152-164. PubMed ID: 32219435
[TBL] [Abstract][Full Text] [Related]
27. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
Elting LS; Cooksley CD; Chambers MS; Garden AS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
[TBL] [Abstract][Full Text] [Related]
28. Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis.
Chaitanya B; Pai KM; Yathiraj PH; Fernandes D; Chhaparwal Y
Oral Oncol; 2017 Sep; 72():179-182. PubMed ID: 28797456
[TBL] [Abstract][Full Text] [Related]
29. Neuropathic pain prevalence and risk factors in head and neck cancer survivors.
Rojo RD; Ren JL; Lipe DN; Badr H; Shete S; Hanna EY; Reyes-Gibby CC
Head Neck; 2022 Dec; 44(12):2820-2833. PubMed ID: 36129114
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of tapentadol prolonged release for the management of painful mucositis in head and neck cancers during intensity modulated radiation therapy.
Rosario M; Francesco R; Sergio F; Niccolò GL; Alba F; Maurizio N; Sergio A; Stefania G; Filippo A
Support Care Cancer; 2016 Oct; 24(10):4451-5. PubMed ID: 27448104
[TBL] [Abstract][Full Text] [Related]
31. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer.
Cerchietti LC; Navigante AH; Lutteral MA; Castro MA; Kirchuk R; Bonomi M; Cabalar ME; Roth B; Negretti G; Sheinker B; Uchima P
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1330-7. PubMed ID: 16765532
[TBL] [Abstract][Full Text] [Related]
32. Douleur Neuropathique 4 (DN4) stratifies possible and definite neuropathic pain after surgical peripheral nerve lesion.
Aho T; Mustonen L; Kalso E; Harno H
Eur J Pain; 2020 Feb; 24(2):413-422. PubMed ID: 31660676
[TBL] [Abstract][Full Text] [Related]
33. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.
Trotti A; Bellm LA; Epstein JB; Frame D; Fuchs HJ; Gwede CK; Komaroff E; Nalysnyk L; Zilberberg MD
Radiother Oncol; 2003 Mar; 66(3):253-62. PubMed ID: 12742264
[TBL] [Abstract][Full Text] [Related]
34. Status of hydration assessed by bioelectrical impedance analysis: a valuable predictive factor for radiation-induced oral mucositis in head and neck cancer patients.
Brzozowska A; Mlak R; Gołębiowski P; Małecka-Massalska T
Clin Transl Oncol; 2019 May; 21(5):615-620. PubMed ID: 30327938
[TBL] [Abstract][Full Text] [Related]
35. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy.
Yokota T; Tachibana H; Konishi T; Yurikusa T; Hamauchi S; Sakai K; Nishikawa M; Suzuki M; Naganawa Y; Hagihara T; Tsumaki H; Kubo T; Sato M; Taguri M; Morita S; Eguchi T; Kubota K; Zenda S
Support Care Cancer; 2016 Jul; 24(7):3029-36. PubMed ID: 26887378
[TBL] [Abstract][Full Text] [Related]
36. Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt & soda mouthwashes.
Dodd MJ; Miaskowski C; Greenspan D; MacPhail L; Shih AS; Shiba G; Facione N; Paul SM
Cancer Invest; 2003; 21(1):21-33. PubMed ID: 12643006
[TBL] [Abstract][Full Text] [Related]
37. Opioid therapy vs. multimodal analgesia in head and neck Cancer (OPTIMAL-HN): study protocol for a randomized clinical trial.
Zayed S; Lang P; Mendez LC; Read N; Sathya J; Venkatesan V; Moulin DE; Warner A; Palma DA
BMC Palliat Care; 2021 Mar; 20(1):45. PubMed ID: 33740977
[TBL] [Abstract][Full Text] [Related]
38. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.
Rastogi M; Khurana R; Revannasiddaiah S; Jaiswal I; Nanda SS; Gupta P; Chufal KS; Bhatt ML
Support Care Cancer; 2017 May; 25(5):1439-1443. PubMed ID: 27987094
[TBL] [Abstract][Full Text] [Related]
39. The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation: a single-center, randomized, prospective study of a calcium phosphate mouth rinse + standard of care versus standard of care.
Lambrecht M; Mercier C; Geussens Y; Nuyts S
Support Care Cancer; 2013 Oct; 21(10):2663-70. PubMed ID: 23686379
[TBL] [Abstract][Full Text] [Related]
40. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
